Healthcare
HSA to expand role in accelerating biomedical sector growth: Ong Ye Kung
HSA to expand role in accelerating biomedical sector growth: Ong Ye Kung
The authority plans to strengthen its position as a global reference regulator.
Surgical robotics market to reach $30b by 2034
The Asia Pacific region is expected to witness the fastest growth.
Asian medical device markets face cost shocks amidst Iran conflict
The Strait of Hormuz is the chokepoint of the market.
Global dental articulators market to reach $227.8m by 2030
Growth is driven by ageing populations and new articulator designs.
Australia grants $450,000 funding boost to fast-track cancer trials
This brings total investments to $975,000.
Australia kicks off first stage of $630m Fairfield Hospital project
This includes plans for a new 460-space multi-storey car park.
Intelligent wound closure fuels surgical stapler market to $10.3b
The Asia-Pacific is emerging as the fastest-growing market.
SGH and Redesign Health to build startups, new tech in 3-year deal
Under the MoU, SGH will provide access to clinicians and research, amongst others.
KPJ Healthcare opens first neuroscience centre at Damansara hospital
It provides 24-hour access to advanced CT and MRI.
Lipid nanoparticles market to reach $3.1b by 2033 as chronic diseases rise
The adoption of mRNA-based vaccines will also fuel demand.
Reproductive health disorders to drive female tech market to $26.1b by 2033
It will expand at a compound annual growth rate of 15.2%.
Burjeel Holdings net profit rises 39.5% YoY to $136.9m
Total revenue also increased by 9.5% YoY to $1.47b.
Global prescription drugs market to reach $2.26t by 2034
The Asia Pacific region is projected to register the fastest growth rate.
IHH Healthcare FY2025 net profit falls 21% to $682.67m
The decrease is due to unrealised currency translation losses from a stronger ringgit.
Sunway Healthcare targets $4.34b market cap with Malaysia IPO
Proceeds from the listing will partially fund its expansion.
2026 biotech playbook: Hong Kong at the centre of China’s globalisation
Hong Kong increasingly provides durable, repeat access to capital for public biotech firms.
Hong Kong outlines ‘One plus Three’ model for life and health tech R&D
A headquarters for the Life and Health Technology Research Institutes will be set up.
Most Read
1. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 2. Health ministry unveils homegrown AI model built for patients 3. China’s healthcare defies Hang Seng slump with 0.9% gain 4. India rolls out terminology, drug registry 5. DNA diagnostics market to reach $24.7b by 2034 on precision medicine, genomic advancementsResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential